slotkoers
Shenzhen S.E.
00:00:00 24-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
29,95
CNY
|
-3,14%
|
|
-6,90%
|
+3,42%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
6.210
|
5.481
|
7.138
|
10.662
|
6.786
|
7.124
|
-
|
-
|
Bedrijfswaarde
1 |
6.210
|
5.481
|
7.138
|
10.662
|
6.786
|
7.124
|
7.124
|
7.124
|
K/w-verhouding
|
30,5
x
|
18,7
x
|
18,8
x
|
20,2
x
|
11,6
x
|
10,6
x
|
9,3
x
|
8,15
x
|
Dividendrendement
|
1,13%
|
1,5%
|
2,63%
|
-
|
6,91%
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
3,45
x
|
3,01
x
|
3,52
x
|
4,55
x
|
2,73
x
|
2,54
x
|
2,25
x
|
2
x
|
Bedrijfswaarde/omzet
|
3,45
x
|
3,01
x
|
3,52
x
|
4,55
x
|
2,73
x
|
2,54
x
|
2,25
x
|
2
x
|
Bedrijfswaarde/EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfswaarde/FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
3,59
x
|
2,8
x
|
3,26
x
|
4,13
x
|
2,28
x
|
2,24
x
|
2,09
x
|
1,95
x
|
Aantal aandelen (in duizenden)
|
234.331
|
234.331
|
234.331
|
234.331
|
234.331
|
234.331
|
-
|
-
|
Referentieprijs
2 |
26,50
|
23,39
|
30,46
|
45,50
|
28,96
|
30,40
|
30,40
|
30,40
|
Datum van publicatie
|
6/03/20
|
15/01/21
|
18/01/22
|
19/01/23
|
20/01/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
1.800
|
1.820
|
2.027
|
2.341
|
2.484
|
2.809
|
3.169
|
3.556
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
414,2
|
612,7
|
818,1
|
1.160
|
1.326
|
1.520
|
1.728
|
1.952
|
Operationele Marge
|
23,01%
|
33,67%
|
40,36%
|
49,56%
|
53,37%
|
54,11%
|
54,53%
|
54,89%
|
Resultaat voor belastingen (EBT)
1 |
414,4
|
619,7
|
821,1
|
1.159
|
1.325
|
1.519
|
1.727
|
1.951
|
Nettowinst (verlies)
1 |
204,1
|
292,3
|
380,3
|
526,9
|
585,3
|
669,9
|
766,5
|
873,9
|
Nettomarge
|
11,34%
|
16,06%
|
18,76%
|
22,51%
|
23,56%
|
23,85%
|
24,19%
|
24,57%
|
WPA
2 |
0,8700
|
1,250
|
1,620
|
2,250
|
2,500
|
2,855
|
3,270
|
3,730
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF-marge
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
0,3000
|
0,3500
|
0,8000
|
-
|
2,000
|
-
|
-
|
-
|
Datum van publicatie
|
6/03/20
|
15/01/21
|
18/01/22
|
19/01/23
|
20/01/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
12,3%
|
15,9%
|
18,1%
|
22,1%
|
21,1%
|
21,1%
|
24,4%
|
28,6%
|
ROA (netto-inkomsten/totale activa)
|
6,75%
|
8,49%
|
9,98%
|
-
|
11,8%
|
-
|
-
|
-
|
Totale activa
1 |
3.026
|
3.442
|
3.810
|
-
|
4.944
|
-
|
-
|
-
|
Nettoactief per aandeel
2 |
7,390
|
8,340
|
9,340
|
11,00
|
12,70
|
13,60
|
14,60
|
15,60
|
Cashflow per aandeel
2 |
1,040
|
3,140
|
2,710
|
5,110
|
5,010
|
5,380
|
6,160
|
6,900
|
Capex
|
172
|
-
|
120
|
-
|
48,7
|
-
|
-
|
-
|
Capex/omzet
|
9,58%
|
-
|
5,93%
|
-
|
1,96%
|
-
|
-
|
-
|
Datum van publicatie
|
6/03/20
|
15/01/21
|
18/01/22
|
19/01/23
|
20/01/24
|
-
|
-
|
-
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +3,42% | 981 mln. | | +55,19% | 815 mld. | | +45,71% | 654 mld. | | -6,09% | 354 mld. | | +21,92% | 337 mld. | | +19,57% | 247 mld. | | +3,93% | 229 mld. | | +13,97% | 219 mld. | | +10,86% | 171 mld. | | -2,78% | 159 mld. |
Farmaceutische producten - Andere
|